Table 3.
Hematological parameters and total protein in the control group (CG) and iron treatment group (ITG) at baseline (T1) and after 3 weeks (T2).
| Group | T1 | T2 | p | η 2 p |
|---|---|---|---|---|
| Transferrin (mg/dL) | ||||
| CG | 243.3 ± 25.4 | 234.4 ± 24.2 | 0.195 | 0.097 |
| ITG | 232.0 ± 18.6 | 242.3 ± 44.4 | ||
| Transferrin Saturation Index (%) | ||||
| CG | 31.7 ± 9.6 | 29.9 ± 8.9 | 0.025 | 0.248 |
| ITG | 35.5 ± 10.0 | 31.1 ± 12.9 & | ||
| Total Protein (g/dL) | ||||
| CG | 7.0 ± 0.3 | 7.0 ± 0.6 | 0.017 | 0.290 |
| ITG | 6.9 ± 0.3 | 7.1 ± 0.3 & | ||
| Red Blood Cells (×106 cells/µL) | ||||
| CG | 4.9 ± 0.4 | 4.9 ± 0.4 | <0.001 | 0.815 |
| ITG | 4.8 ± 0.3 | 5.0 ± 0.2 & | ||
Data are expressed as mean ± standard deviation. p: group-by-time interaction (p < 0.05, all such occurrences). Two-factor repeated-measures ANOVA. No significant differences between groups (CG vs. ITG) were found by independent t-tests. & Significant differences (p < 0.05) over time (T1 vs. T2) within the same group as determined by dependent t-tests.